Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-294-9 | CAS number: 11071-47-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: combined repeated dose and reproduction / developmental screening
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as published report, no restrictions, fully adequate for assessment
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- Males and females were exposed to the test substance for 10 weeks prior to pairing.
- Qualifier:
- according to guideline
- Guideline:
- other: US EPA OPPTS 870.3650 (Combined repeated dose toxicity study with the reproductive/developmental toxicity screening test)
- Deviations:
- yes
- Remarks:
- Males and females were exposed to the test substance for 10 weeks prior to pairing.
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Isooctene
- EC Number:
- 234-294-9
- EC Name:
- Isooctene
- Cas Number:
- 11071-47-9
- Molecular formula:
- C8H16
- IUPAC Name:
- 2-methylhept-1-ene
- Details on test material:
- - Name of test material (as cited in study report): isooctene
- Synonym: Di-n-butene
- Physical state: Clear, colourless liquid
- Analytical purity: 99.9%, 99.84% area (gas chromatography)
- Lot/batch No.: K402 distillate
- Expiration date of the lot/batch: Unlimited
- Stability under test conditions: Unlimited
- Storage condition of test material: room temperature; air sensitive, under N2
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH; Sandhofer Weg 7, 97633 Sulzfeld
- Age at study initiation: Approximately 6 weeks
- Weight at study initiation: group mean range 161.7-166.6 g (males), 126.1-131.0 g (females)
- Housing: Individually in wire cages
- Diet: Milled mouse/rat laboratory diet (Provimi Kliba SA, Kaiseraugst, Basel Switzerland) ad libitum except during exposure and motor activity measurements
- Water: tap ad libitum except during exposure and motor activity measurements
- Acclimatisation period: Approximately two weeks
ENVIRONMENTAL CONDITIONS
- Temperature: 20-24°C
- Humidity: 30-70%
- Air changes (per hr): Not reported; air-conditioned
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 13 June 2006 To: 26 April 2007
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- other: air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: glass-steel inhalation chamber, volume of about 1.4 m³ (BASF Aktiengesellschaft).
- Air flow: Approximately 20 per hour
- Air conditions: Test group 0: A positive pressure was maintained by adjusting the airflow of the exhaust air system. This ensured that no laboratory air reached the control animals.
Test groups 1 - 3: A negative pressure was maintained by adjusting the airflow of the exhaust air system. This ensured that the laboratory was not contaminated as the result of any leakage from the inhalation chamber.
- System of generating particulates/aerosols: For each concentration the test substance was supplied to a thermostated vaporizer at a constant rate by means of the metering pump.
- Temperature, humidity, pressure in air chamber: The vapour was generated with conditioned supply air (actual range 54.6-61.1% relative humidity, temperature 20.9-22.7°C) and passed into the inhalation system.
TEST ATMOSPHERE
- Brief description of analytical method used: The nominal concentration was calculated from the study means of the test pump rates and the supply airflows used during exposure to generate the respective concentrations.
The concentrations of the inhalation atmospheres were analyzed by gas chromatography in all test groups including control.
- Total hydrocarbon analyzers were used to continuously monitor the constancy of concentrations of test substance vapours in the inhalation systems.
- No surveillance of the oxygen content in the inhalation system was performed. The air change within the inhalation systems was judged to be sufficient to prevent oxygen depletion by the breathing of the animals and the concentrations of the test substance used could not have a substantial influence on oxygen partial pressure. - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: 16 days
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 post coitum - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The vapour generation effectiveness was as expected for these high concentrations (range of 83.9-88.8%). Real time surveillance of the inhalation atmospheres with total hydrocarbon analyzers generally proved the constancy of each concentration throughout the daily exposures.
- Duration of treatment / exposure:
- Males were treated for approx. 13 weeks (10 weeks premating, 3 weeks mating and post mating). In females treatment was performed during premating (10 weeks), mating and gestation through day 4 after delivery (approx. 15 weeks).
- Frequency of treatment:
- 6 hours per day / 5 days per week
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 1000, 5000 and 15000 mg/m3
Basis:
other: target concentration
- Remarks:
- Doses / Concentrations:
0, 1200, 5600 and 16900 mg/m3
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
0, 1000±100, 5000±200 and 14900±700 mg/m3
Basis:
analytical conc.
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, sham-exposed
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: The clinical conditions of the test animals were recorded at least 3 times (before, during and after exposure) on exposure days and once during the preflow period, on the day of neurofunctional test and prior to gross necropsy. During exposure only a group wise examination was possible.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Detailed clinical observations were performed in all animals prior to the exposure period and thereafter in weekly intervals.
BODY WEIGHT: Yes
- Time schedule for examinations: The body weight of all parental animals was determined on day -5 (start preflow period), on day 0 (start exposure period) and then in weekly intervals as well as prior to gross necropsy. Female parental animals were weighed on days 0, 7, 14 and 20 post coitum and on days 1 and 4 post partum. Parental females without litters were not weighed.
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes, with the following exceptions; Food consumption was not determined during the mating period, food consumption of the parental females with evidence of sperm was determined for days 0-7, 7-14 and 14-20 post coitum, food consumption of parental females, which gave birth to a litter was determined for days 1-4 post partum.
FOOD EFFICIENCY:
- Food efficiency (group means) was calculated based upon individual values for body weight and food consumption.
MATING AND REPRODUCTIVE PERFORMANCE: Yes
Male and female mating and fertility indices (%) and female gestation index (%) were calculated. - Oestrous cyclicity (parental animals):
- None
- Sperm parameters (parental animals):
- None
- Litter observations:
- PUP NUMBER AND STATUS AT DELIVERY: Parameters assessed: number and sex of pups, stillbirths, live births.
PUP VIABILITY/MORTALITY: Examined once or twice/day. Numbers of dead pups on day of birth (day 0) and dying between days 1-4 of lactation determined. Viability index (%) was calculated.
SEX RATIO: Determined on day 0 and day 4
CLINICAL OBSERVATIONS: Assessed daily
PUP BODYWEIGHTS: weighed on days 1 and 4 after birth - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals after the females began littering
- Maternal animals: All surviving animals when the offspring were 4 days old
GROSS NECROPSY
- Gross necropsy of all animals
HISTOPATHOLOGY / ORGAN WEIGHTS
- Selected organs were weighed (adrenals, brain, heart, kidneys, liver, lungs, ovaries, testes, spleen, thymus and uterus)
- Comprehensive range of tissues was prepared for microscopic examination (all gross lesions, brain, spinal cord (cervical, thoracic and lumbar), sciatic nerve, pituitary gland, salivary glands, thyroid/parathyroid glands, adrenal glands, prostate gland, seminal vesicles, coagulation glands, uterus, oviducts, vagina, female mammary gland, thymus, lymph nodes, spleen, trachea, lungs, heart, aorta, liver, pancreas, kidneys, oesophagus, stomach, duodenum, jejunum, ileum, caecum, colon, rectum, urinary bladder, sternum with marrow, bone marrow (femur), head (with nasal cavities), larynx, pharynx, eyes with optic nerve, femur with knee joint, skin, skeletal muscle, extraorbital lachrymal glands). - Postmortem examinations (offspring):
- All surviving pups on day 4 post partum, all stillborn and any decedents were examined externally, eviscerated and organs assessed macroscopically.
- Statistics:
- Means and standard deviations of each test group were calculated for parameters measured. Further statistical analyses were performed as appropriate, according to the methods of Dunnett’s t-test (two-sided), Fisher’s Exact test, Wilcoxon test (one-sided), and/or Kruskal-Wallis test (two-sided).
- Reproductive indices:
- Male and female mating and fertility indices (%) and female gestation index (%)
- Offspring viability indices:
- Pup viability index (%)
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
Details on results (P0)
There was no mortality. Clinically, slight ataxia (from day 9 onward) and salivation (from day 8 onward) were observed at 15000 mg/m3 indicating marginal irritation and systemic toxicity of Isooctene.
BODY WEIGHT AND WEIGHT GAIN
In male animals the mean body weight and body weight change were found to be significantly decreased when compared with the controls.
FOOD CONSUMPTION
A transient decrease of food consumption was observed in male and female animals on study day 7, which did not occur again after the animals adjusted to the test substance and the exposure procedure.
FOOD EFFICIENCY
In male animals, food efficiency were found to be significantly decreased when compared with the controls.
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
The fertility indices for F0 males were 90, 100, 90 and 100% for the control, 1000 mg/m3, 5000 mg/m3 and 15000 mg/m3 groups respectively. The female mating index was 100% for the control, 1000 mg/m3 and 15000 mg/m3 groups and 90% for the 5000 mg/m3 group.
The gestation index was 100% in the 5000 and 15000 mg/m³ groups, 89% in the control group and 90% in the 1000 mg/m³ group. The number of liveborn and stillborn pups was comparable between all test groups. Thus, the live birth index amounted to 100% in the 5000 mg/m³ group, 99% in 15000 mg/m³ group, 98% in the control group and 96% in the 1000 mg/m³ group.
ORGAN WEIGHTS (PARENTAL ANIMALS)
Absolute and relative liver and kidney weights of males were significantly increased in animals exposed to 5000 and 15000 mg Isooctene/m3.
HISTOPATHOLOGY (PARENTAL ANIMALS)
The treatment-related microscopic changes observed were increased hyaline cast(s) and basophilic cortical tubules in the kidneys of male animals from group 2 (5000 mg/m3) onward. In addition, in males there was suspected greater propensity for the development of large hyaline droplets related to the proximal tubules compared to controls. Mallory-Heidenhain stain of all male kidneys and immunhistochemistry of selected male kidneys with an alpha 2u globulin antibody revealed a concentration-dependent accumulation of alpha 2u globulin in cortical tubular cells in all treated groups. However, in the absence of any treatment-related morphological signs of cytotoxicity, the minimal to slight accumulation of alpha 2u globulin in the group 1000 mg/m3 males is regarded to be adaptive and non-adverse in character.
In the respiratory tract no signs of toxicity were observed.
Effect levels (P0)
- Dose descriptor:
- NOAEC
- Remarks:
- reproductive toxicity
- Effect level:
- 15 000 other: mg/m3 (target concentration)
- Sex:
- male/female
- Basis for effect level:
- other: No effects on fertility and pre/postnatal development
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Gross pathological findings:
- no effects observed
Details on results (F1)
No adverse effects on the development of offspring until postnatal day 4 were noted in the litters of all exposed groups.
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this test, isooctene did not influence fertility or pre/postnatal development at dose levels as high as 15000 mg/m3.
The NOAEC for developmental toxicity was 15000 mg/m3 for male and female rats. - Executive summary:
Wistar rats were exposed, whole body, to 0, 1000, 5000 and 15000 mg/m3 isooctene vapour for 6 hours/day, 5 days/week. Males were exposed for approximately 13 weeks (10 weeks pre-mating, 3 weeks mating and post mating). Females were exposed during pre-mating (10 weeks), mating and gestation through day 4 after delivery (approximately 15 weeks). The parental animals were examined for their mating and reproductive performances. The pups were sexed and were weighed on the day after birth and on day 4 post partum. Their viability was recorded. All pups underwent necropsy on day 4 post partum and were examined macroscopically for external and visceral findings.
The capability to cohabitate and to generate offspring was not affected in either sex.
Under the conditions of this test, isooctene did not influence fertility at dose levels as high as 15000 mg/m3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.